Combination therapy using nucleic acids and conventional drugs

Details Combination therapy using nucleic acids and conventional drugs Combination therapy using nucleic acids and conventional drugs

2005-01-11

2005-01-11

Reynolds, Deborah J. (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C514S001000

Reexamination Certificate

active

06841537

ABSTRACT:
The present invention relates to methods for increasing the efficiency of transformation of cycling cells, the methods comprising synchronizing cells at a first stage of the cell cycle, and transforming the cells at a second stage of the cell cycle within about one cell cycle of the first stage with a genetically engineered nucleic acid that encodes a desired gene product. The invention further relates to cancer therapy and, in particular, to methods of efficiently transforming cancer cells with nucleic acids that encode gene products that inhibit the growth of cancer cells.

REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 5571797 (1996-11-01), Ohno et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5591601 (1997-01-01), Wagner et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5688773 (1997-11-01), Chiocca et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5747469 (1998-05-01), Roth et al.
patent: 6041252 (2000-03-01), Walker et al.
patent: 0 760 675 (2001-01-01), None
patent: 1548621 (1979-07-01), None
patent: WO 9207943 (1992-05-01), None
patent: WO 9400095 (1994-01-01), None
patent: WO 9508994 (1995-04-01), None
patent: WO 9640964 (1996-12-01), None
patent: WO 9641875 (1996-12-01), None
Bischoff et al., “An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.” Science, vol. 274: 373-376, Oct. 1996.*
Lee et al., “Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.” Cancer Res. vol. 56: 1303-1308, Mar. 1996.*
Krek et al., “Cell synchronization.” Methods Enzymol., vol. 254: 114-24, 1995.*
Crystal R., “Transfer of genes to humans: Early lessons and obstacles to success.” Science, vol. 270: 404-410, 1995.*
Dachs et al., “Targeting gene therapy to cancer: A Review.” Oncology Res., vol. 9: 313-325, 1997.*
Verma et al., “Gene therapy-promises, problems and prospects.” Nature, vol. 389: 239-242, Sep. 1997.*
Deonarain M., “Ligand-targeted receptor-mediated vectors for gene delivery.” Exp. Opin. Ther. Patents, vol. 8(1): 53-69, 1998.*
Miller et al., “Targeted vectors for gene therapy.” FASEB, vol. 9:190-199, Feb. 1995.*
Orkin et al., “Report and recommendations of the panel to assess the NIH investment in research on gene therapy.” pp. 1-20, Dec. 1995.*
Brigham, et al.,Am. J. Med. Sci., 298(4):278-281 (1989).
Cohen,Immunol. Today, 14(3):126-130 (1993).
Gavrieli, et al.,J. Cell Biol, 119(3): 493-501 (1992).
Hyde, et al.,Nature, 362:250-256 (1993).
Ikegami, et al.,Nature, 275:458-460 (1978).
Keyomarsi, et al.,Cancer Research, 51: 3602-3609 (1991).
Legendre, et al.,Pharm. Res., 9(10):1235-1242 (1992).
Lunardi-Iskandar, et al.,Clin. Exp. Immunol., 60:285-293 (1985).
Peters,Nature, 371:204-205 (1994).
Sherr,Cell, 73:1059-1065 (1993).
Son, et al.,Proc. Natl. Acad. Sci. USA, 91: 12669-12672 (1994).
Tseng, et al.,Biotechnol. Bioeng., 50:548-554 (1996).
Wahl, et al.,Biochemistry, 25:7821-7837 (1986).
White, et al.,J. Virol., 52(2):410-419 (1984).
Zabner, et al.,J. Biol. Chem., 270(32):18997-19007 (1995).
Zhu, et al.,Science, 261:209-211 (1993).
Cone, et al.,Proc. Natl. Acad. Sci. USA, 81:6349-6353 (1984).
Eglitis, et al.,Biotechniques, 6(7):608-614 (1988).
Gilboa, et al.,BioTechniques, 4(6):504-512 (1986).
Mann, et al.,Cell, 33:153-159 (1983).
Miller, et al.,BioTechniques, 7(9):981-990 (1989).

Affiliated with

Also associated with

Rating

Combination therapy using nucleic acids and conventional drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy using nucleic acids and conventional drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using nucleic acids and conventional drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3411764